BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 29542106)

  • 1. Breast surgery for metastatic breast cancer.
    Tosello G; Torloni MR; Mota BS; Neeman T; Riera R
    Cochrane Database Syst Rev; 2018 Mar; 3(3):CD011276. PubMed ID: 29542106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial breast irradiation for early breast cancer.
    Hickey BE; Lehman M; Francis DP; See AM
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD007077. PubMed ID: 27425375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour bed boost radiotherapy for women after breast-conserving surgery.
    Kindts I; Laenen A; Depuydt T; Weltens C
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011987. PubMed ID: 29105051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial breast irradiation for early breast cancer.
    Lehman M; Hickey BE; Francis DP; See AM
    Cochrane Database Syst Rev; 2014 Jun; (6):CD007077. PubMed ID: 24938937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fulvestrant for hormone-sensitive metastatic breast cancer.
    Lee CI; Goodwin A; Wilcken N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011093. PubMed ID: 28043088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary treatment for operable primary breast cancer.
    Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP (Poly ADP-Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer.
    Taylor AM; Chan DLH; Tio M; Patil SM; Traina TA; Robson ME; Khasraw M
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011395. PubMed ID: 33886122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platinum-containing regimens for metastatic breast cancer.
    Egger SJ; Willson ML; Morgan J; Walker HS; Carrick S; Ghersi D; Wilcken N
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD003374. PubMed ID: 28643430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncoplastic breast-conserving surgery for women with primary breast cancer.
    Nanda A; Hu J; Hodgkinson S; Ali S; Rainsbury R; Roy PG
    Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013658. PubMed ID: 34713449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates and other bone agents for breast cancer.
    O'Carrigan B; Wong MH; Willson ML; Stockler MR; Pavlakis N; Goodwin A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003474. PubMed ID: 29082518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes.
    Verma R; Chandarana M; Barrett J; Anandadas C; Sundara Rajan S
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD014463. PubMed ID: 37327075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial breast irradiation versus whole breast radiotherapy for early breast cancer.
    Hickey BE; Lehman M
    Cochrane Database Syst Rev; 2021 Aug; 8(8):CD007077. PubMed ID: 34459500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxane-containing regimens for metastatic breast cancer.
    Ghersi D; Willson ML; Chan MM; Simes J; Donoghue E; Wilcken N
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD003366. PubMed ID: 26058962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravesical Bacillus Calmette-Guérin with interferon-alpha versus intravesical Bacillus Calmette-Guérin for treating non-muscle-invasive bladder cancer.
    Shepherd AR; Shepherd E; Brook NR
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD012112. PubMed ID: 28268259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fraction size in radiation therapy for breast conservation in early breast cancer.
    Hickey BE; James ML; Lehman M; Hider PN; Jeffery M; Francis DP; See AM
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD003860. PubMed ID: 27425588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin-sparing mastectomy for the treatment of breast cancer.
    Mota BS; Bevilacqua JLB; Barrett J; Ricci MD; Munhoz AM; Filassi JR; Baracat EC; Riera R
    Cochrane Database Syst Rev; 2023 Mar; 3(3):CD010993. PubMed ID: 36972145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trastuzumab-containing regimens for metastatic breast cancer.
    Balduzzi S; Mantarro S; Guarneri V; Tagliabue L; Pistotti V; Moja L; D'Amico R
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006242. PubMed ID: 24919460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up strategies for women treated for early breast cancer.
    Moschetti I; Cinquini M; Lambertini M; Levaggi A; Liberati A
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD001768. PubMed ID: 27230946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
    Eleje GU; Eke AC; Ezebialu IU; Ikechebelu JI; Ugwu EO; Okonkwo OO
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012464. PubMed ID: 30141832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination versus sequential single agent chemotherapy for metastatic breast cancer.
    Dear RF; McGeechan K; Jenkins MC; Barratt A; Tattersall MH; Wilcken N
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD008792. PubMed ID: 24347031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.